LeMaitre Vascular, Inc.
LMAT
$95.91
$0.100.10%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 234.64M | 226.26M | 219.86M | 213.03M | 205.62M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 234.64M | 226.26M | 219.86M | 213.03M | 205.62M |
| Cost of Revenue | 72.48M | 70.60M | 68.96M | 67.45M | 66.41M |
| Gross Profit | 162.16M | 155.66M | 150.90M | 145.58M | 139.21M |
| SG&A Expenses | 92.48M | 87.00M | 83.00M | 79.59M | 76.62M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 179.87M | 173.25M | 167.61M | 163.42M | 159.98M |
| Operating Income | 54.77M | 53.01M | 52.26M | 49.61M | 45.64M |
| Income Before Tax | 60.88M | 58.32M | 56.88M | 54.17M | 49.44M |
| Income Tax Expenses | 13.77M | 13.16M | 12.84M | 12.85M | 11.76M |
| Earnings from Continuing Operations | 47.12 | 45.16 | 44.04 | 41.32 | 37.68 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 47.12M | 45.16M | 44.04M | 41.32M | 37.68M |
| EBIT | 54.77M | 53.01M | 52.26M | 49.61M | 45.64M |
| EBITDA | 64.87M | 62.85M | 61.93M | 59.24M | 55.24M |
| EPS Basic | 2.09 | 2.01 | 1.96 | 1.84 | 1.69 |
| Normalized Basic EPS | 1.69 | 1.62 | 1.58 | 1.51 | 1.38 |
| EPS Diluted | 2.05 | 1.97 | 1.93 | 1.82 | 1.66 |
| Normalized Diluted EPS | 1.66 | 1.60 | 1.56 | 1.49 | 1.37 |
| Average Basic Shares Outstanding | 90.17M | 90.01M | 89.81M | 89.58M | 89.36M |
| Average Diluted Shares Outstanding | 91.53M | 91.36M | 91.03M | 90.59M | 90.24M |
| Dividend Per Share | 0.72 | 0.68 | 0.64 | 0.62 | 0.60 |
| Payout Ratio | 34.45% | 33.89% | 32.65% | 33.63% | 35.60% |